Methyl 1-(2-fluoro-6-methylphenyl)-4-hydrazinyl-6-oxopyridazine-3-carboxylate
C13H13FN4O3 — CID 163361015
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 1-(2-fluoro-6-methylphenyl)-4-hydrazinyl-6-oxopyridazine-3-carboxylate
Methyl 1-(2-fluoro-6-methylphenyl)-4-hydrazinyl-6-oxopyridazine-3-carboxylate (PubChem CID 163361015) has the molecular formula C13H13FN4O3 and a molecular weight of 292.27 g/mol. Its IUPAC name is methyl 1-(2-fluoro-6-methylphenyl)-4-hydrazinyl-6-oxopyridazine-3-carboxylate.
Molecular Properties
| Compound Name | Methyl 1-(2-fluoro-6-methylphenyl)-4-hydrazinyl-6-oxopyridazine-3-carboxylate |
|---|---|
| PubChem CID | 163361015 |
| Molecular Formula | C13H13FN4O3 |
| Molecular Weight | 292.27 g/mol |
| Exact Mass | 292.10 |
| IUPAC Name | methyl 1-(2-fluoro-6-methylphenyl)-4-hydrazinyl-6-oxopyridazine-3-carboxylate |
| SMILES | COC(=O)c1nn(-c2c(C)cccc2F)c(=O)cc1NN |
| InChI | InChI=1S/C13H13FN4O3/c1-7-4-3-5-8(14)12(7)18-10(19)6-9(16-15)11(17-18)13(20)21-2/h3-6,16H,15H2,1-2H3 |
| InChIKey | UZENEADUQMRSPD-UHFFFAOYSA-N |
| XLogP | 0.75 |
| TPSA | 99.24 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 292.27 |
| LogP ≤ 5 | 0.75 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163361015 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.